Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis

Author:

Harris Kristina M.1,Smilek Dawn E.2,Byron Margie3,Lim Noha1,Barry William T.3,McNamara James4,Garcet Sandra5,Konrad Robert J.6,Stengelin Martin7,Bathala Pradeepthi7,Korman Neil J.8,Feldman Steven R.9,Boh Erin E.10,Barber Kirk11,Laumann Anne E.12,Helfrich Yolanda Rosi13,Krueger Gerald G.14,Sofen Howard15,Bissonnette Robert16,Krueger James G.5

Affiliation:

1. Biomarker and Discovery Research, Immune Tolerance Network, University of California, San Francisco, San Francisco

2. Clinical Trials Group, Clinical and Translational Medicine, Immune Tolerance Network, University of California, San Francisco, San Francisco

3. Rho Inc, Durham, North Carolina

4. Autoimmunity and Mucosal Immunology Branch, Division of Allergy, Immunology, and Transplantation/National Institute of Allergy and Infectious Diseases, Rockville, Maryland

5. The Rockefeller University, New York, New York

6. Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana

7. Meso Scale Diagnostics LLC, Rockville, Maryland

8. Department of Dermatology, University Hospitals Cleveland Medical Center, Cleveland, Ohio

9. Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina

10. Health Sciences Center, Tulane University School of Medicine, New Orleans, Louisiana

11. Department of Medicine (Dermatology), University of Calgary, Calgary, Alberta, Canada

12. Department of Dermatology, Northwestern University, Colorado Springs, Colorado

13. Dermatology Clinic, University of Michigan Medicine, Ann Arbor

14. Department of Dermatology, University of Utah School of Medicine, Salt Lake City

15. Dermatology, David Geffen UCLA (University of California, Los Angeles) School of Medicine, Los Angeles

16. Innovaderm, Montreal, Quebec, Canada

Publisher

American Medical Association (AMA)

Subject

Dermatology

Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3